Using Immuno-Oncological Biomarker-Directed Strategies as a Blueprint For Developing Effective Treatments for Alzheimer’s DiseaseMonday, 28 October 2019 at 12:30 Add to Calendar ▼2019-10-28 12:30:002019-10-28 13:30:00Europe/LondonUsing Immuno-Oncological Biomarker-Directed Strategies as a Blueprint For Developing Effective Treatments for Alzheimer’s DiseaseImmuno-Oncology Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com INmune Bio approaches Alzheimer’s disease (AD) as an immunological disease, not a neurological disease. This changes the clinical strategy in many ways but perhaps none more important than we now have biomarkers. We have developed a suite of biomarkers that extend beyond classical blood inflammatory measures that will inform go/no decisions. |